相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression and regulation of non-classical HLA-G in renal cell carcinoma
K. Dunker et al.
TISSUE ANTIGENS (2008)
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells
A. Nazmul H. Khan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Immune-refractory cancers and their little helpers - An extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Joerg Wischhusell et al.
SEMINARS IN CANCER BIOLOGY (2007)
Clinical and biological significance of HLA-G expression in ovarian cancer
Jim Jinn-Chyuan Sheu et al.
SEMINARS IN CANCER BIOLOGY (2007)
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
Nathalie Rouas-Freiss et al.
SEMINARS IN CANCER BIOLOGY (2007)
Soluble HLA-G: Are they clinically relevant?
Vito Pistoia et al.
SEMINARS IN CANCER BIOLOGY (2007)
Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer
Shang-Mian Yie et al.
LUNG CANCER (2007)
Epigenetic control of the immune escape mechanisms in malignant carcinomas
A. Francesca Setiadi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
HLA-G expression in human ovarian carcinoma counteracts NK cell function
A. Lin et al.
ANNALS OF ONCOLOGY (2007)
Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders
Yasmine Sebti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release
Fabio Morandi et al.
CANCER RESEARCH (2007)
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2′-deoxycytidine in cutaneous melanoma:: Immunotherapeutic implications
Ester Fonsatti et al.
CLINICAL CANCER RESEARCH (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer
Shang-rong Ye et al.
MODERN PATHOLOGY (2007)
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines
Teresa Rodriguez et al.
BMC CANCER (2007)
Immune selective pressure and HLA class I antigen defects in malignant lesions
Chien-Chung Chang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Immunoepigenetics: the unseen side of cancer immunoediting
A. E. Germenis et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Epigenetic regulation of immune escape genes in cancer
Thomas B. Tomasi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
David S. Schrump et al.
CLINICAL CANCER RESEARCH (2006)
NK cell activating ligands on human malignant cells: Molecular and functional defects and potential clinical relevance
Chien-Chung Chang et al.
SEMINARS IN CANCER BIOLOGY (2006)
Phase I trial of sequential low-dose 5-aza-2′-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma
Jared A. Gollob et al.
CLINICAL CANCER RESEARCH (2006)
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications
S Coral et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Histone H4-K16 acetylation controls chromatin structure and protein interactions
M Shogren-Knaak et al.
SCIENCE (2006)
Epigenetics provides a new generation of oncogenes and tumour-suppressor genes
M Esteller
BRITISH JOURNAL OF CANCER (2006)
De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
ZS Guo et al.
CANCER RESEARCH (2006)
The role of HLA-G in human pregnancy
Joan S. Hunt et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2006)
MHC class II molecules in tumour immunology: Prognostic marker and target for immune modulation
M. E. D. Chamuleau et al.
IMMUNOBIOLOGY (2006)
Epigenetic regulation of MHC-II and CIITA genes
Kenneth L. Wright et al.
TRENDS IN IMMUNOLOGY (2006)
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction
A Eramo et al.
CANCER RESEARCH (2005)
How do CD4+CD25+ regulatory T cells control autoimmunity?
JA Bluestone et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Regulatory T cells and tumor immunity
S Chattopadhyay et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells
SD Chou et al.
INTERNATIONAL IMMUNOLOGY (2005)
Regulation of MHC class II gene expression by the class II transactivator
W Reith et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Towards the human cancer epigenome - A first draft of histone modifications
MF Fraga et al.
CELL CYCLE (2005)
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine
JC Chuang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Rational development of histone deacetylase inhibitors as anticancer agents: A review
MR Acharya et al.
MOLECULAR PHARMACOLOGY (2005)
Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways
F Natoni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis
L Moretta et al.
IMMUNOLOGY LETTERS (2005)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Silence from within: Endogenous siRNAs and miRNAs
EJ Sontheimer et al.
CELL (2005)
The role of the RNAi machinery in heterochromatin formation
M Wassenegger
CELL (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies
KN Bhalla
JOURNAL OF CLINICAL ONCOLOGY (2005)
Understanding the response to immunotherapy in humans
E Wang et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
DNA methylation and demethylation as targets for anticancer therapy
M Szyf
BIOCHEMISTRY-MOSCOW (2005)
Arginine methylation: An emerging regulator of protein function
MT Bedford et al.
MOLECULAR CELL (2005)
Phylogenetic shadowing and computational identification of human microRNA genes
E Berezikov et al.
CELL (2005)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway
A Insinga et al.
NATURE MEDICINE (2005)
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
C Demanet et al.
BLOOD (2004)
Animal models of tumor immunity, immunotherapy and cancer vaccines
S Ostrand-Rosenberg
CURRENT OPINION IN IMMUNOLOGY (2004)
Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)
Y Takamura et al.
GLIA (2004)
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
JPJ Issa et al.
BLOOD (2004)
Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
Y Morimoto et al.
BRITISH JOURNAL OF CANCER (2004)
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells
PS Moore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
被撤回的出版物: Induction of DNA methylation and gene silencing by short interfering RNAs in human cells (Retracted article. See vol 441, pg 1176, 2006)
H Kawasaki et al.
NATURE (2004)
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activation of natural killer cells:: Underlying molecular mechanisms revealed
E Backström et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
An epigenetically altered tumor cell vaccine
ANH Khan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti et al.
CANCER RESEARCH (2004)
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells
DM Lucas et al.
LEUKEMIA (2004)
Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells
A Satoh et al.
ONCOGENE (2004)
Regulation of p53 activity through lysine methylation
S Chuikov et al.
NATURE (2004)
Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells
H Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Histone deacetylase inhibitors: Understanding a new wave of anticancer agents
A Villar-Garea et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix
A Chil et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2003)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP
N Lee et al.
JOURNAL OF IMMUNOLOGY (2003)
Differential in vivo and in vitro HLA-G expression in melanoma cells:: Potential mechanisms
CC Chang et al.
HUMAN IMMUNOLOGY (2003)
HLA-G in melanoma: can the current controversies be solved?
CC Chang et al.
SEMINARS IN CANCER BIOLOGY (2003)
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
M Altomonte et al.
ONCOGENE (2003)
Epigenetic targets for immune intervention in human malignancies
M Maio et al.
ONCOGENE (2003)
Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines
JY Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Heterochromatin and epigenetic control of gene expression
SIS Grewal et al.
SCIENCE (2003)
Methylation-regulated expression of HLA class I antigens in melanoma
E Fonsatti et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies:: a multimechanism therapeutic approach?
L Sigalotti et al.
BLOOD (2003)
An epigenetic road map for histone lysine methylation
M Lachner et al.
JOURNAL OF CELL SCIENCE (2003)
Relevance of DNA methylation in the management of cancer
M Esteller
LANCET ONCOLOGY (2003)
Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas
T Kanaseki et al.
JOURNAL OF IMMUNOLOGY (2003)
BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs)
EG Chiorean et al.
BLOOD (2003)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
MR Bernsen et al.
BRITISH JOURNAL OF CANCER (2003)
Adoptive transfer of an anti-MART-127-35-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice
F Lozupone et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Histone lysine methylation: a signature for chromatin function
RJ Sims et al.
TRENDS IN GENETICS (2003)
Senescence and epigenetic dysregulation in cancer
P Neumeister et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
MJ Scanlan et al.
IMMUNOLOGICAL REVIEWS (2002)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor
L Di Croce et al.
SCIENCE (2002)
Lack of IFN-γ-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines
N van der Stoep et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Defective death receptor signaling as a cause of tumor immune escape
LE French et al.
SEMINARS IN CANCER BIOLOGY (2002)
Expression of HLA class I antigens and restoration of antigen-specific ctl response in melanoma cells following 5-aza-2′-deoxycytidine treatment
A Serrano et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas
Y Nie et al.
CARCINOGENESIS (2001)
Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription
F Fuks et al.
EMBO JOURNAL (2001)
Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells
N Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
WJ Magner et al.
JOURNAL OF IMMUNOLOGY (2000)
Transcriptional repression by Blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase
J Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Antigen-processing machinery breakdown and tumor growth
B Seliger et al.
IMMUNOLOGY TODAY (2000)
Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA
PJ van den Elsen et al.
HUMAN IMMUNOLOGY (2000)
分享论文
